JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7594 Salermide

Summary: SIRT1 and SIRT2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥46.8 mg/mL
B7715 ML 00253764 hydrochloride

Summary: melanocortin MC4 receptor antagonist

insoluble in H2O; <41.37 mg/mL
C6524 Laurocapram

≥26.5 mg/mL
A4137 AZD1480
2 Citation

Target: JAK

Summary: JAK2 inhibitor,ATP-competitive and novel

insoluble in H2O; ≥93.8 mg/mL
A4164 AZD2461

Target: PARP

Summary: Novel PARP inhibitor

insoluble in H2O; ≥16.35 mg/mL
A4032 VX-222 (VCH-222, Lomibuvir)

Target: HCV polymerase

Summary: NNI of HCV RNA polymerase

≥44.6 mg/mL
A4096 Belinostat (PXD101)
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A4120 MK-5108 (VX-689)
1 Citation

Summary: Aurora-A kinase inhibitor,highly selective

≥23.1 mg/mL
A4010 Salinosporamide A (NPI-0052, Marizomib)

Target: Proteasome

Summary: 20S proteasome inhibitor

Soluble in DMSO